102
Views
1
CrossRef citations to date
0
Altmetric
Theme: Biomarkers: paving the way for better stratification in heart failure - Review

Use of B-type natriuretic peptide in critically ill patients

, &
Pages 541-547 | Published online: 08 Oct 2009

Bibliography

  • Iwanaga Y , NishiI, FuruichiSet al. : B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.J. Am. Coll. Cardiol.47(4), 742–748 (2006).
  • Stein BC , LevinRI: Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.Am. Heart J.135(5 Pt 1), 914–923 (1998).
  • van Kimmenade RR , JanuzziJL Jr, Bakker JA et al.: Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J. Am. Coll. Cardiol.53(10), 884–890 (2009).
  • Schou M , AlehagenU, GoetzeJP, GustafssonF, DahlstromU: Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals.Heart95, 1514–1519 (2009).
  • Mueller C , BreidthardtT, Laule-KilianK, ChristM, PerruchoudAP: The integration of BNP and NT-proBNP into clinical medicine.Swiss Med. Wkly137(1–2), 4–12 (2007).
  • Maisel AS , KrishnaswamyP, NowakRMet al. : Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N. Engl. J. Med.347(3), 161–167 (2002).
  • McLean AS , TangB, NalosM, HuangSJ, StewartDE: Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients.Anaesth. Inten. Care31(1), 21–27 (2003).
  • Charpentier J , LuytCE, FullaYet al. : Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis.Crit. Care Med.32(3), 660–665 (2004).
  • Roch A , Allardet-ServentJ, MicheletPet al. : NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients.Crit. Care Med.33(5), 1001–1007 (2005).
  • Karmpaliotis D , KirtaneAJ, RuisiCPet al. : Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.Chest131(4), 964–971 (2007).
  • Kucher N , GoldhaberSZ: Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism.Circulation108(18), 2191–2194 (2003).
  • Grabowski M , FilipiakKJ, MalekLAet al. : Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.Int. J. Cardiol.115(3), 386–390 (2007).
  • McLean AS , HuangSJ, HyamsSet al. : Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock.Crit. Care Med.35(4), 1019–1026 (2007).
  • Ware LB , MatthayMA: Clinical practice. Acute pulmonary edema.N. Engl. J. Med.353(26), 2788–2796 (2005).
  • Maeder M , AmmannP, RickliH, DiethelmM: Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome.Swiss Med. Wkly133(37–38), 515–518 (2003).
  • Jefic D , LeeJW, JeficD, Savoy-MooreRT, RosmanHS: Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients.Chest128(1), 288–295 (2005).
  • Bal L , ThierryS, BrocasEet al. : B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.Acta Anaesthesiol. Scand.50(3), 340–347 (2006).
  • Forfia PR , WatkinsSP, RameJE, StewartKJ, ShapiroEP: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.J. Am. Coll. Cardiol.45(10), 1667–1671 (2005).
  • Rana R , VlahakisNE, DanielsCEet al. : B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema.Crit. Care Med.34(7), 1941–1946 (2006).
  • Levitt JE , VinayakAG, GehlbachBKet al. : Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study.Crit. Care12(1), R3 (2008).
  • Thierry S , LecuyerL, BrocasEet al. : Interest of the brain natriuretic peptide as a marker of acute cor pulmonale in acute respiratory distress syndrome.Ann. Fr. Anesth. Reanim.25(8), 815–819 (2006).
  • Bando M , IshiiY, SugiyamaY, KitamuraS: Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale.Respir. Med.93(7), 507–514 (1999).
  • Wiedemann HP , WheelerAP, BernardGRet al. : Comparison of two fluid-management strategies in acute lung injury.N. Engl. J. Med.354(24), 2564–2575 (2006).
  • Abroug F , Ouanes-BesbesL, NciriNet al. : Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.Am. J. Respir. Crit. Care Med.174(9), 990–996 (2006).
  • Januzzi JL Jr, Camargo CA, Anwaruddin S et al.: The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol.95(8), 948–954 (2005).
  • Stolz D , BreidthardtT, Christ-CrainMet al. : Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease.Chest133(5), 1088–1094 (2008).
  • Lemaire F , TeboulJL, CinottiLet al. : Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation.Anesthesiology69(2), 171–179 (1988).
  • Mekontso-Dessap A , de Prost N, Girou E et al.: B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med.32(10), 1529–1536 (2006).
  • Chien JY , LinMS, HuangYC, ChienYF, YuCJ, YangPC: Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial.Crit. Care Med.36(5), 1421–1426 (2008).
  • Ait-Oufella H , TharauxPL, BaudelJLet al. : Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study.Intensive Care Med.33(7), 1183–1186 (2007).
  • Witthaut R , BuschC, FraunbergerPet al. : Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.Intensive Care Med.29(10), 1696–1702 (2003).
  • Pirracchio R , DeyeN, LukaszewiczACet al. : Impaired plasma B-type natriuretic peptide clearance in human septic shock.Crit. Care Med.36(9), 2542–2546 (2008).
  • Tung RH , GarciaC, MorssAMet al. : Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock.Crit. Care Med.32(8), 1643–1647 (2004).
  • Januzzi JL , MorssA, TungRet al. : Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study.Crit. Care10(1), R37 (2006).
  • Rudiger A , GasserS, FischlerM, HornemannT, von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit. Care Med.34(8), 2140–2144 (2006).
  • Nikolaou NI , GoritsasC, DedeMet al. : Brain natriuretic peptide increases in septic patients without severe sepsis or shock.Eur. J. Intern. Med.18(7), 535–541 (2007).
  • Shor R , RozenmanY, BolshinskyAet al. : BNP in septic patients without systolic myocardial dysfunction.Eur. J. Intern. Med.17(8), 536–540 (2006).
  • Tanaka T , KandaT, TakahashiT, SaegusaS, MoriyaJ, KurabayashiM: Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes.J. Int. Med. Res.32(1), 57–61 (2004).
  • Ma KK , OgawaT, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J. Mol. Cell. Cardiol.36(4), 505–513 (2004).
  • He Q , LaPointeMC: Interleukin-1b regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.Hypertension33(1 Pt 2), 283–289 (1999).
  • Mekontso-Dessap A , TualL, KirschMet al. : B-type natriuretic peptide to assess haemodynamic status after cardiac surgery.Br. J. Anaesth.97(6), 777–782 (2006).
  • Logeart D , LecuyerL, ThabutGet al. : Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism.Intensive Care Med.33(2), 286–292 (2007).
  • Pieralli F , OlivottoI, VanniSet al. : Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism.Am. J. Cardiol.97(9), 1386–1390 (2006).
  • Kruger S , GrafJ, MerxMWet al. : Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism.Am. Heart J.147(1), 60–65 (2004).
  • Klok FA , MosIC, HuismanMV: Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.Am. J. Respir. Crit. Care Med.178(4), 425–430 (2008).
  • Lega JC , LacasseY, LakhalL, ProvencherS: Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis. Thorax doi: 10.1136/thx.2008.110965 (2009) (Epub ahead of print)].
  • Jarai R , FellnerB, HaoulaDet al. : Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.Crit. Care Med.37(6), 1837–1844 (2009).
  • Brueckmann M , HuhleG, LangSet al. : Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.Circulation112(4), 527–534 (2005).
  • Shah KB , NolanMM, RaoKet al. : The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients.Am. J. Med.120(12), 1071–1077 (2007).
  • Meyer B , HuelsmannM, WexbergPet al. : N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.Crit. Care Med.35(10), 2268–2273 (2007).
  • Hutfless R , KazanegraR, MadaniMet al. : Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.J. Am. Coll. Cardiol.43(10), 1873–1879 (2004).
  • Pedrazzini GB , MassonS, LatiniRet al. : Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.Am. J. Cardiol.102(6), 749–754 (2008).
  • Roques F , MichelP, GoldstoneAR, NashefSA: The logistic EuroSCORE.Eur. Heart J.24(9), 881–882 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.